Your session is about to expire
← Back to Search
3D Printed Stents for Head and Neck Cancer
N/A
Waitlist Available
Led By Eugene J Koay
Research Sponsored by M.D. Anderson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Eastern Cooperative Oncology Group performance status (ECOG PS) 0-2
Patient is dispositioned to receive definitive or adjuvant radiotherapy for treatment of a diagnosed head and neck malignancy
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 2 months
Awards & highlights
Study Summary
This trial compares a 3D-printed stent to a dentist-made stent to help patients with head and neck cancer during radiation therapy with fewer appointments and lower cost.
Who is the study for?
This trial is for patients with head and neck cancer who need an oral stent as part of their radiation therapy. They must be treated at MD Anderson Cancer Center, have a performance status score of 0-2, consent to the study, and have pre-treatment imaging that includes their teeth. Patients with prior head and neck radiotherapy or severe trismus are excluded.Check my eligibility
What is being tested?
The trial is testing a customized 3D-printed oral stent against traditional dentist-made stents in patients receiving radiation therapy for head and neck cancer. The focus is on comparing effectiveness in preventing side effects and efficiency in turnaround time for device delivery.See study design
What are the potential side effects?
While this trial primarily focuses on the efficacy of the stent devices rather than medication, potential discomforts may include issues related to wearing an oral device such as irritation inside the mouth or difficulty speaking or swallowing.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am able to get out of my bed or chair and move around.
Select...
I am set to receive radiotherapy for my head or neck cancer.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 2 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 2 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
To evaluate whether a customized 3 dimensional (3D) printed oral stent achieves non-inferior levels of patient reported outcomes as the standard dental-fabricated oral stents at the time prior to starting treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: 3D printed stent+ MDASI-3D Oral Stents QuestionnaireExperimental Treatment2 Interventions
Patients wear a customized 3D printed oral stent over 5-10 minutes in the supine position at the time of radiation simulation, before starting radiation therapy, and in the 3rd to 5th week of radiation therapy. Patients may also optionally wear the commercially-made stent called TruGuard at these timepoints. Ancillary Studies (MDASI-3D Oral Stents Questionnaire)
Find a Location
Who is running the clinical trial?
M.D. Anderson Cancer CenterLead Sponsor
2,966 Previous Clinical Trials
1,804,724 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,654 Previous Clinical Trials
40,933,096 Total Patients Enrolled
Eugene J KoayPrincipal InvestigatorM.D. Anderson Cancer Center
5 Previous Clinical Trials
273 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am able to get out of my bed or chair and move around.I can barely open my mouth (less than 10mm).I am set to receive radiotherapy for my head or neck cancer.I have had radiotherapy for head or neck cancer.My oncologist has approved an oral stent made by MDACC for my treatment.I have had imaging done of my jaw and teeth before treatment.
Research Study Groups:
This trial has the following groups:- Group 1: 3D printed stent+ MDASI-3D Oral Stents Questionnaire
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are any new participants being accepted into this experiment?
"According to the clinicaltrials.gov web page, this therapeutic trial is no longer looking for patients as it was last modified on October 14th 2022. Despite that, there are 395 other research studies currently recruiting participants."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger